Browsing: Emerging Disease
The first citywide deployment of Wolbachia has proved successful, with no dengue cases reported since Wolbachia became established.
Following a study that shed new light on the psychiatric and neurological problems suffered by Ebola survivors, researchers are calling for more specialist support for this population.
Primarily transferred via direct contact with the blood or bodily fluids of infected people, the Ebola virus receives a significant boost to its infective properties from amyloid fibrils in human semen, according to a new study.
At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
At the recent Microbiology Society Annual Conference (10–12 April, Birmingham, UK) we spoke to Mark Wass about his work on Ebolaviruses in which he’s delved into the molecular determinants of the virus’s pathogenicity.